184 related articles for article (PubMed ID: 9658316)
1. Reduced expression and rare genomic alteration of nm23-H1 in human hepatocellular carcinoma and hepatoma cell lines.
Fujimoto Y; Ohtake T; Nishimori H; Ikuta K; Ohhira M; Ono M; Kohgo Y
J Gastroenterol; 1998 Jun; 33(3):368-75. PubMed ID: 9658316
[TBL] [Abstract][Full Text] [Related]
2. NM23-H1 and NM23-H2 messenger RNA abundance in human hepatocellular carcinoma.
Iizuka N; Oka M; Noma T; Nakazawa A; Hirose K; Suzuki T
Cancer Res; 1995 Feb; 55(3):652-7. PubMed ID: 7530600
[TBL] [Abstract][Full Text] [Related]
3. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].
Liu Y; Chen X; Peng S; Fang H; Wu Y; Peng C; Shi L; Bai M; Xu B; Wang J; Deng G
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1553-6. PubMed ID: 12609066
[TBL] [Abstract][Full Text] [Related]
4. Nm23-H1 expression in intrahepatic or extrahepatic metastases of hepatocellular carcinoma.
Shimada M; Taguchi K; Hasegawa H; Gion T; Shirabe K; Tsuneyoshi M; Sugimachi K
Liver; 1998 Oct; 18(5):337-42. PubMed ID: 9831363
[TBL] [Abstract][Full Text] [Related]
5. Transfection of the nm23-H1 gene into human hepatocarcinoma cell line inhibits the expression of sialyl Lewis X, alpha1,3 fucosyltransferase VII, and metastatic potential.
Liu F; Zhang Y; Zhang XY; Chen HL
J Cancer Res Clin Oncol; 2002 Apr; 128(4):189-96. PubMed ID: 11935309
[TBL] [Abstract][Full Text] [Related]
6. Expression of human nm23-H1 and nm23-H2 proteins in hepatocellular carcinoma.
Yamaguchi A; Urano T; Goi T; Takeuchi K; Niimoto S; Nakagawara G; Furukawa K; Shiku H
Cancer; 1994 May; 73(9):2280-4. PubMed ID: 8168032
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of N-acetylglucosaminyltransferase V by tumorigenesis- or metastasis-suppressor gene and its relation to metastatic potential of human hepatocarcinoma cells.
Guo HB; Liu F; Zhao JH; Chen HL
J Cell Biochem; 2000 Sep; 79(3):370-85. PubMed ID: 10972975
[TBL] [Abstract][Full Text] [Related]
8. Expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma.
Liu YB; Gao SL; Chen XP; Peng SY; Fang HQ; Wu YL; Peng CH; Tang Z; Xu B; Wang JW; Deng GL; Li HJ; Feng XD; Qian HR
World J Gastroenterol; 2005 Mar; 11(9):1378-81. PubMed ID: 15761980
[TBL] [Abstract][Full Text] [Related]
9. Effects of all-trans retinoic acid and epidermal growth factor on the expression of nm23-H1 in human hepatocarcinoma cells.
Liu F; Qi HL; Chen HL
J Cancer Res Clin Oncol; 2000 Feb; 126(2):85-90. PubMed ID: 10664247
[TBL] [Abstract][Full Text] [Related]
10. [Relationships between intrahepatic metastasis of hepatocellular carcinoma and in situ microenvironment, and the abundance of nm23-H1 H-ras mRNA].
Zheng X; Lin Z; Liu Y
Zhonghua Zhong Liu Za Zhi; 1998 Jan; 20(1):15-7. PubMed ID: 10921047
[TBL] [Abstract][Full Text] [Related]
11. nm23-H1 expression and disease recurrence after surgical resection of small hepatocellular carcinoma.
Boix L; Bruix J; Campo E; Sole M; Castells A; Fuster J; Rivera F; Cardesa A; Rodes J
Gastroenterology; 1994 Aug; 107(2):486-91. PubMed ID: 8039626
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of nucleoside diphosphate/kinase A/nm23-H1 protein in human lung tumors: association with tumor progression in squamous carcinoma.
Gazzeri S; Brambilla E; Negoescu A; Thoraval D; Veron M; Moro D; Brambilla C
Lab Invest; 1996 Jan; 74(1):158-67. PubMed ID: 8569178
[TBL] [Abstract][Full Text] [Related]
13. Significance of nm23 mRNA expression in human hepatocellular carcinoma.
Lin LI; Lee PH; Wu CM; Lin JK
Anticancer Res; 1998; 18(1B):541-6. PubMed ID: 9568175
[TBL] [Abstract][Full Text] [Related]
14. [Expression of metastasis suppressor gene nm23 in human hepatocellular carcinoma].
Chen X; Dai Y; Yang J
Zhonghua Bing Li Xue Za Zhi; 1996 Apr; 25(2):76-8. PubMed ID: 9206208
[TBL] [Abstract][Full Text] [Related]
15. Activation of antimetastatic Nm23-H1 gene expression by estrogen and its alpha-receptor.
Lin KH; Wang WJ; Wu YH; Cheng SY
Endocrinology; 2002 Feb; 143(2):467-75. PubMed ID: 11796500
[TBL] [Abstract][Full Text] [Related]
16. Association between nm23-H1 expression, proliferation and apoptosis in non-small cell lung carcinomas.
Volm M; Mattern J; Koomägi R
Clin Exp Metastasis; 1998 Oct; 16(7):595-602. PubMed ID: 9932606
[TBL] [Abstract][Full Text] [Related]
17. High nm23-H1/NDPK-A expression in Ewing tumors: paradoxical immunohistochemical reactivity and lack of prognostic significance.
Aryee DN; Ströbel T; Kos K; Salzer-Kuntschik M; Zoubek A; Veron M; Ambros IM; Traincart F; Gadner H; Kovar H
Int J Cancer; 1995 Apr; 64(2):104-11. PubMed ID: 7542225
[TBL] [Abstract][Full Text] [Related]
18. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
[TBL] [Abstract][Full Text] [Related]
19. nm23--relationship to the metastatic potential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients.
Russell RL; Geisinger KR; Mehta RR; White WL; Shelton B; Kute TE
Cancer; 1997 Mar; 79(6):1158-65. PubMed ID: 9070493
[TBL] [Abstract][Full Text] [Related]
20. High frequency of concomitant nm23-H1 and E-cadherin transcriptional inactivation in primary non-inheriting colorectal carcinomas.
Garinis GA; Manolis EN; Spanakis NE; Patrinos GP; Peros G; Menounos PG
J Mol Med (Berl); 2003 Apr; 81(4):256-63. PubMed ID: 12684753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
